Reuters logo
4 months ago
BRIEF-Inventiva SA says topline results of FASST Phase 2b clinical trial anticipated in H2 2018
April 10, 2017 / 4:26 PM / 4 months ago

BRIEF-Inventiva SA says topline results of FASST Phase 2b clinical trial anticipated in H2 2018

1 Min Read

April 10 (Reuters) - Inventiva SA:

* FASST Phase 2b clinical trial on track to complete enrollment in second half of 2017

* Topline results of FASST Phase 2b clinical trial anticipated in second half of 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below